INTERCEPT PHARMACEUTICALS, INC.·4

May 17, 4:01 PM ET

Richardson Linda M 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed May 17, 2022

Insider Transaction Report

Form 4
Period: 2022-05-15
Richardson Linda M
EVP & Chief Commercial Officer
Transactions
  • Tax Payment

    Common Stock

    2022-05-15$17.88/sh124$2,21733,798 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Documents

1 file
  • 4
    tm2215871-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT